Furthermore, AIM2’s inflammasome-independent role in inhibiting colon cancer is mediated by the suppression of DNA-dependent protein kinase (DNA-PK) activation and Akt signaling pathways (54). Here, AIM2 is linked to malignant colon neoplasm.